| Name | tert-butyl (3S,5S)-2-oxo-5-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate |
|---|---|
| Synonyms |
(3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester
(3S,5S)-3-(1-Methylethyl)-2-oxo-5-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]-1-pyrrolidinecarboxylic acid tert-butyl ester (3S,5S)-tert-Butyl 3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-2-oxopyrrolidine-1-carboxylate |
| Molecular Formula | C19H31NO5 |
|---|---|
| Molecular Weight | 353.45300 |
| Exact Mass | 353.22000 |
| PSA | 72.91000 |
| LogP | 3.32020 |
|
~%
934841-17-5 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GmbH Patent: WO2007/45420 A2, 2007 ; Location in patent: Page/Page column 63-64 ; |
|
~%
934841-17-5 |
| Literature: NOVARTIS AG Patent: WO2008/119804 A1, 2008 ; Location in patent: Page/Page column 61-62 ; WO 2008/119804 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |